Overview
A comprehensive perioperative nutrition management plan for pancreaticoduodenectomy, primarily based on pancreatic enzyme replacement therapy (PERT). A prospective randomized controlled study was conducted to comprehensively analyze the perioperative nutritional status of patients undergoing pancreaticoduodenectomy, with the aim of exploring:
- The effect of PERT on postoperative complications and physiological status after pancreaticoduodenectomy;
- The efficacy of PERT treatment on clinical symptoms, nutritional indicators, and quality of life (QOL) related to pancreatic exocrine dysfunction (PEI) after pancreaticoduodenectomy;
- The personalized full process nutrition management strategies based on risk factor stratification.
Eligibility
Inclusion Criteria:
- Gender unlimited, 18-80 years old;
- Patients undergoing pancreaticoduodenectomy due to various benign or malignant diseases;
- Voluntary testing with informed consent.
Exclusion Criteria:
- Pregnant women and lactating women
- Patients with distant metastasis based on tumor staging before surgery;
- Tumor recurrence;
- Refuse to sign the consent form.